EPISODE · Jul 16, 2013 · 5 MIN
Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech
from The Biopharma Pod · host William Reed Ltd
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.
What this episode covers
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.
NOW PLAYING
Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m